Pregnant women with SLE with active disease and major organ involvement have a higher risk of thrombosis, premature delivery, preeclampsia, eclampsia, pregnancy loss and maternal mortality.
RSLV-132 is not a first-line treatment, but it may be particularly promising for some of the 60 to 80 percent of lupus patients with skin manifestations.
Cleveland Clinic’s multidisciplinary Lupus Clinic was established by the Department of Rheumatic and Immunologic Diseases to integrate the management of patients with SLE and provide comprehensive, leading-edge care.
A 29-year-old woman is referred to Cleveland Clinic Lupus Clinic with multiple symptoms. The physician team creates a treatment strategy that results in rapid resolution of many problems.